Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 111

1.

The effects of methadone on immune function among injecting drug users: a review.

McLachlan C, Crofts N, Wodak A, Crowe S.

Addiction. 1993 Feb;88(2):257-63. Review.

PMID:
8220063
2.

The effect of methadone on immunological parameters among HIV-positive and HIV-negative drug users.

Carballo-Diéguez A, Sahs J, Goetz R, el Sadr W, Sorell S, Gorman J.

Am J Drug Alcohol Abuse. 1994 Aug;20(3):317-29.

PMID:
7977217
3.

Drug use and HIV/AIDS in China.

Liu Z, Lian Z, Zhao C.

Drug Alcohol Rev. 2006 Mar;25(2):173-5. Review.

PMID:
16627308
4.

Methadone maintenance and hepatitis C virus infection among injecting drug users.

Crofts N, Nigro L, Oman K, Stevenson E, Sherman J.

Addiction. 1997 Aug;92(8):999-1005.

PMID:
9376782
5.

Factors predicting entry of injecting drug users into substance abuse treatment.

Zule WA, Desmond DP.

Am J Drug Alcohol Abuse. 2000 May;26(2):247-61.

PMID:
10852359
6.
7.

Association of immune activation with intravenous heroin use and methadone treatment in HIV-1 seropositive and seronegative subjects.

Di Franco MJ, Marlink R, Hunter DJ, Tosteson T, Mayer K, Essex M.

J Acquir Immune Defic Syndr. 1993 Dec;6(12):1297-300.

PMID:
8254465
8.
9.

Methadone maintenance and other factors associated with intraindividual temporal trends in injection-drug use.

Shore RE, Marmor M, Titus S, Des Jarlais DC.

J Subst Abuse Treat. 1996 May-Jun;13(3):241-8.

PMID:
9017567
10.

Methadone maintenance treatment and HIV risk-taking behaviour among injecting drug users in Berlin.

Stark K, Müller R, Bienzle U, Guggenmoos-Holzmann I.

J Epidemiol Community Health. 1996 Oct;50(5):534-7.

12.

Costs of hospital-based methadone maintenance treatment in HIV/AIDS control among injecting drug users in Indonesia.

Afriandi I, Siregar AY, Meheus F, Hidayat T, van der Ven A, van Crevel R, Baltussen R.

Health Policy. 2010 Apr;95(1):69-73. doi: 10.1016/j.healthpol.2009.11.003. Epub 2009 Dec 9.

PMID:
20004491
13.

Methadone maintenance and needle/syringe sharing.

Longshore D, Hsieh S, Danila B, Anglin MD.

Int J Addict. 1993 Aug;28(10):983-96.

PMID:
8407026
14.

Evaluation of a cognitive-behavioural intervention for pregnant injecting drug users at risk of HIV infection.

O'Neill K, Baker A, Cooke M, Collins E, Heather N, Wodak A.

Addiction. 1996 Aug;91(8):1115-25.

PMID:
8828240
15.
16.

Absence of antibody to human immunodeficiency virus in long-term, socially rehabilitated methadone maintenance patients.

Novick DM, Joseph H, Croxson TS, Salsitz EA, Wang G, Richman BL, Poretsky L, Keefe JB, Whimbey E.

Arch Intern Med. 1990 Jan;150(1):97-9.

PMID:
2297301
17.

Profiles of self-reported HIV-risk behaviors among injection drug users in methadone maintenance treatment, detoxification, and needle exchange programs.

Mark HD, Nanda J, Davis-Vogel A, Navaline H, Scotti R, Wickrema R, Metzger D, Sochalski J.

Public Health Nurs. 2006 Jan-Feb;23(1):11-9.

PMID:
16460416
18.

Impact of methadone on drug use and risky sex in China.

Qian HZ, Hao C, Ruan Y, Cassell HM, Chen K, Qin G, Yin L, Schumacher JE, Liang S, Shao Y.

J Subst Abuse Treat. 2008 Jun;34(4):391-7. Epub 2007 Sep 14.

PMID:
17869049
19.

Factors associated with client-reported HIV infection among clients entering methadone treatment.

MacGowan RJ, Fichtner RR, Swanson N, Collier C, Kroliczak A, Cole G.

AIDS Educ Prev. 1997 Jun;9(3):205-17.

PMID:
9241388
20.

Validity of three measures of antisociality in predicting HIV risk behaviors in methadone-maintenance patients.

Tourian K, Alterman A, Metzger D, Rutherford M, Cacciola JS, McKay JR.

Drug Alcohol Depend. 1997 Aug 25;47(2):99-107.

PMID:
9298331

Supplemental Content

Support Center